Improving Attention Deficit Hyperactivity Disorder Treatment Adherence and Outcome in Primary Care Settings



Status:Completed
Conditions:Neurology, Psychiatric
Therapuetic Areas:Neurology, Psychiatry / Psychology
Healthy:No
Age Range:6 - 11
Updated:4/21/2016
Start Date:June 2003
End Date:July 2009

Use our guide to learn which trials are right for you!

Improving Medication Use for ADHD in Primary Care

This study will determine the effectiveness of educating pediatricians about attention
deficit hyperactivity disorder treatment guidelines in improving child behavior and
pediatricians' adherence to medication guidelines.

The most effective treatment for improving the core symptoms of inattention, impulsivity and
hyperactivity in children with attention deficit hyperactivity disorder (ADHD) involves the
use of stimulant medications. Most children with ADHD are treated by pediatricians, but the
treatment provided is often less than optimal. This study is designed to see if training for
pediatricians in following guidelines for management of first-line medicines for ADHD leads
to improvement in child behavior, and whether the physicians can adhere to the guidelines.

Over 100 studies have shown that stimulant medications are effective for improving the core
symptoms of Attention Deficit Hyperactivity Disorder (ADHD). Approximately 70% of children
who receive ADHD medications are treated by their primary care pediatrician, but studies
show that management is not always optimal. The present study is designed to see if child
behavior can be improved by training pediatricians in the use of guidelines for treating
ADHD, and whether the physicians can adhere to the guidelines. Twenty-four pediatric
practices were randomized to a treatment as usual or specialized care (receiving training in
guidelines and computer assisted monitoring of patient progress and medication titration).
Children are assessed with parent and teacher reports at baseline, 4-, 9-, and 12-months
post initiation of treatment, and classroom observations of behavior are assessed at
baseline, 6-, and 12-months. Approximately 400 children are to be enrolled.

Inclusion Criteria:

- Presence of ADHD

- Not currently on medication

Exclusion Criteria:

- No serious neurological disorders of sever mental health problems (suicidal behavior,
autism)
We found this trial at
1
site
225 E Chicago Ave
Chicago, Illinois 60611
(312) 227-4000
Ann & Robert H. Lurie Children's Hospital of Chicago Ann & Robert H. Lurie Children
?
mi
from
Chicago, IL
Click here to add this to my saved trials